Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1869 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-17 | 72.0 | 62 | |
RA1869 | IL-1 alpha | 100 | ng/mL | 3 | IL-17 | 77.5 | 52 | ||||
N2759 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-17 | 87.5 | 78 | |
N2759 | IL-1 alpha | 100 | ng/mL | 3 | IL-17 | 88.5 | 62 | ||||
RA1931 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-17 | 81.0 | 63 | |
RA1931 | IL-1 alpha | 100 | ng/mL | 3 | IL-17 | 93.0 | 79 | ||||
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-17 | 87.0 | 63 | |
N2586 | IL-1 alpha | 100 | ng/mL | 3 | IL-17 | 86.5 | 62 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | IL-17 | 71.0 | 63 | |
RA1869 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | IL-17 | 83.0 | 65 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | IL-17 | 65.0 | 53 | |
N2759 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | IL-17 | 77.0 | 61 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | IL-17 | 69.5 | 52 | |
RA1931 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | IL-17 | 79.0 | 79 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | IL-17 | 70.0 | 67 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | IL-17 | 79.0 | 61 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-17 | 93.5 | 54 | |
RA1869 | TNF-a | 100 | ng/mL | 3 | IL-17 | 109.0 | 45 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-17 | 82.5 | 58 | |
N2759 | TNF-a | 100 | ng/mL | 3 | IL-17 | 88.5 | 72 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-17 | 91.5 | 52 | |
RA1931 | TNF-a | 100 | ng/mL | 3 | IL-17 | 108.0 | 43 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-17 | 104.0 | 60 | |
N2586 | TNF-a | 100 | ng/mL | 3 | IL-17 | 103.5 | 66 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | IL-17 | 32.5 | 60 |